AI assistant
FATE THERAPEUTICS INC — Director's Dealing 2020
Dec 15, 2020
34091_dirs_2020-12-15_3753950c-b9d0-4d3f-a91b-187e4ae48a0b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2020-12-14
Reporting Person: Valamehr Bahram (Chief Development Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-14 | Common stock | M | 25000 | $2.90 | Acquired | 112211 | Direct |
| 2020-12-14 | Common stock | S | 1813 | $95.8947 | Disposed | 110398 | Direct |
| 2020-12-14 | Common stock | S | 11765 | $96.6546 | Disposed | 98633 | Direct |
| 2020-12-14 | Common stock | S | 2946 | $97.6959 | Disposed | 95687 | Direct |
| 2020-12-14 | Common stock | S | 3148 | $98.7969 | Disposed | 92539 | Direct |
| 2020-12-14 | Common stock | S | 3822 | $99.7685 | Disposed | 88717 | Direct |
| 2020-12-14 | Common stock | S | 400 | $100.97 | Disposed | 88317 | Direct |
| 2020-12-14 | Common stock | S | 1006 | $102.063 | Disposed | 87311 | Direct |
| 2020-12-14 | Common stock | S | 100 | $102.75 | Disposed | 87211 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-14 | Stock Option (right to buy) | $2.90 | M | 25000 | Disposed | 2026-01-07 | Common Stock (25000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020.
F2: Represents the weighted average sale price of shares sold ranging from $95.23 to $96.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F3: Represents the weighted average sale price of shares sold ranging from $96.23 to $97.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F4: Represents the weighted average sale price of shares sold ranging from $97.27 to $98.24 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F5: Represents the weighted average sale price of shares sold ranging from $98.28 to $99.26 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F6: Represents the weighted average sale price of shares sold ranging from $99.28 to $100.25 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F7: Represents the weighted average sale price of shares sold ranging from $100.48 to $101.41 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F8: Represents the weighted average sale price of shares sold ranging from $101.56 to $102.42 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F9: This option is fully vested.
F10: Not applicable.